DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Yoo DH, Racewicz A, Brzezicki J. et al.
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.
Arthritis Res Ther 2016;
18: 82
We do not assume any responsibility for the contents of the web pages of other providers.